Latest filing published 19 Feb 2025 for Inari Medical, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Donald B. Milder (board member) discloses dealings in Inari Medical, Inc. to SEC (Form 4). We count 27 filings; the first trade dates from 10 May 2021 and the latest from 19 February 2025.
In open-market terms, that means 2 purchases worth €5.4M on one side and 16 sales worth €3.7M on the other. The net balance comes to €1.7M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants and 2 option exercises.
The latest filing, published on 19 February 2025, reports a transaction in Inari Medical, Inc. The latest purchase dates back some time: it was published 870 days ago, on 31 May 2024. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations